These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7334218)

  • 1. C4 haplotype products and partial inhibition of anti-Rodgers sera.
    Nordhagen R; Olaisen B; Teisberg P; Gedde-Dahl T; Thorsby E
    J Immunogenet; 1981 Dec; 8(6):485-91. PubMed ID: 7334218
    [No Abstract]   [Full Text] [Related]  

  • 2. An international reference typing for Ch and Rg determinants on rare human C4 allotypes.
    Rittner C; Tippett P; Giles CM; Mollenhauer E; Berger R; Nordhagen R; Buskjaer L; Bruun-Petersen G; Lamm L; Roos MH
    Vox Sang; 1984; 46(4):224-34. PubMed ID: 6201005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents.
    Contreras M; Armitage SE; Hewitt PE
    Vox Sang; 1984; 47(3):224-35. PubMed ID: 6464421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new case of deficient H phenotype in a secretor].
    Mannessier L
    Rev Fr Transfus Immunohematol; 1983 Nov; 26(5):481-5. PubMed ID: 6665413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISBT Workshop on RBC monoclonal antibodies: report on group 2 (anti-B, -A,B) antibodies.
    Lubenko A; Redman M; Contreras M
    Rev Fr Transfus Immunohematol; 1987 Dec; 30(5):503-13. PubMed ID: 2455322
    [No Abstract]   [Full Text] [Related]  

  • 6. Mouse monoclonal anti-A and anti-B as routine blood grouping reagents: an evaluation.
    Munro AC; Inglis G; Blue A; Sheridan R; Mitchell R
    Med Lab Sci; 1982 Apr; 39(2):123-7. PubMed ID: 7121214
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between the electrophoretically-determined C4M haplotype product and partial inhibition of anti-Cha.
    Nordhagen R; Olaisen B; Teisberg P; Gedde-Dahl T
    J Immunogenet; 1980 Aug; 7(4):301-6. PubMed ID: 6161195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Partial inhibition' of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition.
    Giles CM
    Vox Sang; 1985; 48(3):160-6. PubMed ID: 3984302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AEL: a rare variant of blood group A].
    Medina A; Jiménez JM; Caso F; Rodríguez JM
    Sangre (Barc); 1994 Feb; 39(1):49-51. PubMed ID: 8197519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual nature of the effect of antibodies on electrophoretic mobility of erythrocytes].
    Levin VI; Ianovich EA; Luts LS; Svirnovskiĭ AI
    Gematol Transfuziol; 1983 Sep; 28(9):29-32. PubMed ID: 6628954
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of anti-Chido from serum using autologous red blood cells coated with homologous C4.
    Ellisor SS; Shoemaker MM; Reid ME
    Transfusion; 1982; 22(3):243-5. PubMed ID: 7046160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Partial inhibition' of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants.
    Giles CM
    Vox Sang; 1985; 48(3):167-73. PubMed ID: 2580392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of monoclonal anti-A and anti-B and affinity-purified Ulex europaeus lectin I for forensic blood grouping.
    Gaensslen RE; Lee HC; Carroll JE
    Z Rechtsmed; 1984; 93(4):259-68. PubMed ID: 6532011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity.
    Lambin P; Le Pennec PY; Hauptmann G; Desaint O; Habibi B; Salmon C
    Vox Sang; 1984; 47(3):242-9. PubMed ID: 6464422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-A and anti-B: development as cost-effective reagents.
    Voak D; Lennox E; Sacks S; Milstein C; Darnborough J
    Med Lab Sci; 1982 Apr; 39(2):109-22. PubMed ID: 6811828
    [No Abstract]   [Full Text] [Related]  

  • 16. Early postoperative monitoring of natural anti-A and anti-B isoantibodies in ABO-incompatible living donor renal allografts.
    Reding R; Squifflet JP; Latinne D; De Bruyère M; Pirson Y; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1989-90. PubMed ID: 3274459
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microplate method for reverse ABO typing of bloodstains.
    Mudd JL
    J Forensic Sci; 1986 Apr; 31(2):418-25. PubMed ID: 3711823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ABO compatibility and lymphocytotoxic crossmatch in living-related liver transplantation.
    Hashikura Y; Kawasaki S; Terada M; Ikegami T; Nakazawa Y; Miwa S; Chisuwa H; Kubota T; Tanaka K; Kusama K; Omachi T; Suzuki A
    Transplant Proc; 1998 Feb; 30(1):127-8. PubMed ID: 9474978
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of anti-A monoclonal antibodies.
    Tills D; Bushrod J
    Rev Fr Transfus Immunohematol; 1987 Dec; 30(5):397-403. PubMed ID: 3452885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.